Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Hologic stock in Canada | $73.61

Own Hologic shares in just a few minutes.

Hologic Inc
NASDAQ: HOLX - USD
MEDICAL INSTRUMENTS & SUPPLIES
$73.61
- $0.03 ( - 0.04%)

Hologic Inc is a medical instruments & supplies business based in the US. Hologic shares (HOLX) are listed on the NASDAQ and all prices are listed in US Dollars. Hologic employs 5,814 staff and has a trailing 12-month revenue of around USD$5.7 billion.

How to buy shares in Hologic

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HOLX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Hologic stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Hologic's stock price?

Since the stock market crash in March caused by coronavirus, Hologic's stock price has had significant positive movement.

Its last market close was $73.61, which is 28.56% up on its pre-crash value of $52.59 and 177.88% up on the lowest point reached during the March crash when the stocks fell as low as $26.49.

If you had bought $1,000 worth of Hologic stocks at the start of February 2020, those stocks would have been worth $547.94 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,372.83.

Hologic stock price

Use our graph to track the performance of HOLX stocks over time.

Hologic shares at a glance

Information last updated 2021-10-16.
Latest market close$73.61
52-week range$60.10 - $85.00
50-day moving average $75.53
200-day moving average $70.98
Wall St. target price$85.83
PE ratio 8.9263
Dividend yield N/A (0%)
Earnings per share (TTM) $7.81

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
FREE TRADES
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get 2 free stocks when you open a Wealthsimple Trade personal account and deposit and trade at least $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
BMO InvestorLine
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$9.95
$9.95 + $1.25 per options contract
$0 if conditions met, otherwise $25/quarter
$0 - $9.95
Buy and sell a select group of Canada’s most popular ETFs without paying commissions.
An easy-to-use online trading platform with access to research, tools, and the option to access InvestorLine adviceDirect for additional professional support.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
OFFER
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Get up to 50 free trades. Be one of the first 100 new Qtrade clients to use the promo code 50FREETRADES and deposit a minimum of $10,000 (or top up to $15,000 to get $150 transfer fees waived). Valid until December 31, 2021.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Hologic price performance over time

Historical closes compared with the close of $73.61 from 2021-10-22

1 week (2021-10-12) N/A
1 month (2021-09-20) -4.07%
3 months (2021-07-23) 1.81%
6 months (2021-04-23) 0.34%
1 year (2020-10-23) 8.39%
2 years (2019-10-23) 53.39%
3 years (2018-10-23) 83.11%
5 years (2016-10-21) 93.30%

Is Hologic under- or over-valued?

Valuing Hologic stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hologic's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hologic's P/E ratio

Hologic's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Hologic shares trade at around 9x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Hologic's PEG ratio

Hologic's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7026. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hologic's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hologic's EBITDA

Hologic's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.1 billion.

The EBITDA is a measure of a Hologic's overall financial performance and is widely used to measure a its profitability.

Hologic financials

Revenue TTM $5.7 billion
Operating margin TTM 47.49%
Gross profit TTM $2.5 billion
Return on assets TTM 21.84%
Return on equity TTM 66.32%
Profit margin 35.98%
Book value $15.31
Market capitalisation $17.7 billion

TTM: trailing 12 months

Shorting Hologic shares

There are currently 3.9 million Hologic shares held short by investors – that's known as Hologic's "short interest". This figure is 21% down from 5.0 million last month.

There are a few different ways that this level of interest in shorting Hologic shares can be evaluated.

Hologic's "short interest ratio" (SIR)

Hologic's "short interest ratio" (SIR) is the quantity of Hologic shares currently shorted divided by the average quantity of Hologic shares traded daily (recently around 1.4 million). Hologic's SIR currently stands at 2.71. In other words for every 100,000 Hologic shares traded daily on the market, roughly 2710 shares are currently held short.

However Hologic's short interest can also be evaluated against the total number of Hologic shares, or, against the total number of tradable Hologic shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Hologic's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Hologic shares in existence, roughly 20 shares are currently held short) or 0.0156% of the tradable shares (for every 100,000 tradable Hologic shares, roughly 16 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Hologic.

Hologic's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Hologic.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Hologic's total ESG risk score

Total ESG risk: 28.6

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Hologic's overall score of 28.6 (as at 01/01/2019) is nothing to write home about – landing it in it in the 58th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Hologic is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Hologic's environmental score

Environmental score: 2.95/100

Hologic's environmental score of 2.95 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Hologic is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Hologic's social score

Social score: 11.28/100

Hologic's social score of 11.28 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Hologic is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Hologic's governance score

Governance score: 8.88/100

Hologic's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Hologic is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Hologic's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Hologic scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Hologic has, for the most part, managed to keep its nose clean.

Hologic share dividends

We're not expecting Hologic to pay a dividend over the next 12 months.

Have Hologic's shares ever split?

Hologic's shares were split on a 2:1 basis on 3 April 2008. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hologic shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hologic shares which in turn could have impacted Hologic's share price.

Hologic share price volatility

Over the last 12 months, Hologic's shares have ranged in value from as little as $60.1 up to $85. A popular way to gauge a stock's volatility is its "beta".

HOLX.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hologic's is 1.1794. This would suggest that Hologic's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Hologic overview

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site